Dual-specificity phosphatases in mental and neurological disorders

[1]  Houeto Jean-Luc.  [Parkinson's disease]. , 2022, La Revue du praticien.

[2]  M. Fossett,et al.  Longitudinal Analyses , 2021, Long Time Coming.

[3]  Zhiyun Wang,et al.  Identification of dysregulated genes and pathways of different brain regions in Alzheimer’s disease , 2020, The International journal of neuroscience.

[4]  Yu Tian Wang,et al.  MKP-1 reduces Aβ generation and alleviates cognitive impairments in Alzheimer’s disease models , 2019, Signal Transduction and Targeted Therapy.

[5]  P. Watson.  PTSD as a Public Mental Health Priority , 2019, Current Psychiatry Reports.

[6]  R. Snell,et al.  Cerebral Vitamin B5 (D-Pantothenic Acid) Deficiency as a Potential Cause of Metabolic Perturbation and Neurodegeneration in Huntington’s Disease , 2019, Metabolites.

[7]  H. Takada,et al.  A novel missense PTEN mutation identified in a patient with macrocephaly and developmental delay , 2019, Human genome variation.

[8]  Dipan C. Patel,et al.  Neuron–glia interactions in the pathophysiology of epilepsy , 2019, Nature Reviews Neuroscience.

[9]  R. Gómez-Villafuertes,et al.  Dual-Specificity Phosphatase Regulation in Neurons and Glial Cells , 2019, International journal of molecular sciences.

[10]  John P. Rice,et al.  Identification of common genetic risk variants for autism spectrum disorder , 2019, Nature Genetics.

[11]  W. Kuan,et al.  Parkinson’s Disease: Etiology, Neuropathology, and Pathogenesis , 2018, Parkinson’s Disease: Pathogenesis and Clinical Aspects.

[12]  Hui-ling Wang,et al.  PI3K/AKT/GSK3β/CRMP-2-mediated neuroplasticity in depression induced by stress. , 2018, Neuroreport.

[13]  Dong Chen,et al.  Mitogen-activated protein kinase phosphatase 1 protects PC12 cells from amyloid beta-induced neurotoxicity , 2018, Neural regeneration research.

[14]  C. Nievergelt,et al.  Genetic vulnerability to DUSP22 promoter hypermethylation is involved in the relation between in utero famine exposure and schizophrenia , 2018, npj Schizophrenia.

[15]  K. Korotkov,et al.  Targeting phosphatases of regenerating liver (PRLs) in cancer , 2018, Pharmacology & therapeutics.

[16]  S. Marwaha,et al.  Epidemiology and risk factors for bipolar disorder , 2018, Therapeutic advances in psychopharmacology.

[17]  Yang Zhang,et al.  PRL-3 promotes gastric cancer peritoneal metastasis via the PI3K/AKT signaling pathway in vitro and in vivo , 2018, Oncology letters.

[18]  D. Velakoulis,et al.  Alzheimer’s disease: clinical update on epidemiology, pathophysiology and diagnosis , 2018, Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists.

[19]  C. Taghibiglou,et al.  Elevated nuclear phosphatase and tensin homolog (PTEN) and altered insulin signaling in substantia nigral region of patients with Parkinson’s disease , 2018, Neuroscience Letters.

[20]  Paul J. Harrison,et al.  The Emerging Neurobiology of Bipolar Disorder , 2018, Trends in Neurosciences.

[21]  Zachary S. Lorsch,et al.  Sex-specific transcriptional signatures in human depression , 2017, Nature Medicine.

[22]  Y. Dang,et al.  MicroRNA-101 in the ventrolateral orbital cortex (VLO) modulates depressive-like behaviors in rats and targets dual-specificity phosphatase 1 (DUSP1) , 2017, Brain Research.

[23]  Gerald Liu,et al.  Epilepsy: Treatment Options. , 2017, American family physician.

[24]  C. Nievergelt,et al.  Longitudinal analyses of the DNA methylome in deployed military servicemen identify susceptibility loci for post-traumatic stress disorder , 2017, Molecular Psychiatry.

[25]  I. Zerr,et al.  Cytoskeleton-Associated Risk Modifiers Involved in Early and Rapid Progression of Sporadic Creutzfeldt-Jakob Disease , 2017, Molecular Neurobiology.

[26]  M. Friedman,et al.  Considering future pharmacotherapy for PTSD , 2017, Neuroscience Letters.

[27]  R. D’Ambrosio,et al.  Antiepileptic action of c-Jun N-terminal kinase (JNK) inhibition in an animal model of temporal lobe epilepsy , 2017, Neuroscience.

[28]  A. Lang.  Mindfulness in PTSD treatment. , 2017, Current opinion in psychology.

[29]  M. Setou,et al.  Downregulation of GNA13-ERK network in prefrontal cortex of schizophrenia brain identified by combined focused and targeted quantitative proteomics. , 2017, Journal of proteomics.

[30]  Yuxin Yin,et al.  PTENβ is an alternatively translated isoform of PTEN that regulates rDNA transcription , 2017, Nature Communications.

[31]  Dai Zhang,et al.  Association of oligodendrocytes differentiation regulator gene DUSP15 with autism , 2017, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[32]  R. Kessler,et al.  Undertreatment of people with major depressive disorder in 21 countries , 2017, British Journal of Psychiatry.

[33]  Z. Fišar,et al.  Biological hypotheses and biomarkers of bipolar disorder , 2017, Psychiatry and clinical neurosciences.

[34]  J. Esteban,et al.  PTEN: Local and Global Modulation of Neuronal Function in Health and Disease , 2017, Trends in Neurosciences.

[35]  O. Tysnes,et al.  Epidemiology of Parkinson’s disease , 2017, Journal of Neural Transmission.

[36]  Hui Li,et al.  Correlations of PTEN genetic polymorphisms with the risk of depression and depressive symptoms in a Chinese population. , 2016, Gene.

[37]  S. Danzer,et al.  Disrupted hippocampal network physiology following PTEN deletion from newborn dentate granule cells , 2016, Neurobiology of Disease.

[38]  Anuradha Singh,et al.  The Epidemiology of Global Epilepsy. , 2016, Neurologic clinics.

[39]  A. Rodrigues,et al.  Involvement of PI3K/Akt/GSK-3β and mTOR in the antidepressant-like effect of atorvastatin in mice. , 2016, Journal of psychiatric research.

[40]  E. Nestler,et al.  Epigenetic Basis of Mental Illness , 2016, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[41]  D. Charney,et al.  Understanding resilience: New approaches for preventing and treating PTSD , 2016, Experimental Neurology.

[42]  L. Nguyen,et al.  Elongator controls cortical interneuron migration by regulating actomyosin dynamics , 2016, Cell Research.

[43]  K. Blennow,et al.  Alzheimer's disease , 2016, The Lancet.

[44]  M. McCarthy,et al.  Disinhibition of the extracellular-signal-regulated kinase restores the amplification of circadian rhythms by lithium in cells from bipolar disorder patients , 2016, European Neuropsychopharmacology.

[45]  S. Sveinbjornsdottir.  The clinical symptoms of Parkinson's disease , 2016, Journal of neurochemistry.

[46]  A. Rodrigues,et al.  Involvement of PI3K/Akt Signaling Pathway and Its Downstream Intracellular Targets in the Antidepressant-Like Effect of Creatine , 2016, Molecular Neurobiology.

[47]  Seon-Guk Choi,et al.  Dual‐specificity phosphatase 26 (DUSP26) stimulates Aβ42 generation by promoting amyloid precursor protein axonal transport during hypoxia , 2016, Journal of neurochemistry.

[48]  Y. Kitagishi,et al.  Roles of PTEN with DNA Repair in Parkinson’s Disease , 2016, International journal of molecular sciences.

[49]  Johnny C. Tenegra,et al.  Substance Abuse Screening and Treatment. , 2016, Primary care.

[50]  W. V. van IJcken,et al.  Inefficient DNA Repair Is an Aging-Related Modifier of Parkinson’s Disease , 2016, Cell reports.

[51]  S. Romac,et al.  Genetics of Lafora progressive myoclonic epilepsy: current perspectives , 2016, The application of clinical genetics.

[52]  E. Beghi.  Addressing the burden of epilepsy: Many unmet needs. , 2016, Pharmacological research.

[53]  Yongliang Zhang,et al.  Regulatory Roles of MAPK Phosphatases in Cancer , 2016, Immune network.

[54]  I. Slutsky,et al.  Targeting PTEN interactions for Alzheimer's disease , 2016, Nature Neuroscience.

[55]  T. Jiang,et al.  Clinicopathological factors predictive of postoperative seizures in patients with gliomas , 2016, Seizure.

[56]  N. Volkow,et al.  Neurobiologic Advances from the Brain Disease Model of Addiction. , 2016, The New England journal of medicine.

[57]  M. Serrano,et al.  PTEN recruitment controls synaptic and cognitive function in Alzheimer's models , 2016, Nature Neuroscience.

[58]  M. Owen,et al.  Schizophrenia , 2016, The Lancet.

[59]  P. Roach.  Glycogen phosphorylation and Lafora disease. , 2015, Molecular aspects of medicine.

[60]  J. Guinovart,et al.  Brain glycogen in health and disease. , 2015, Molecular aspects of medicine.

[61]  Han-Ming Shen,et al.  PRL-3 activates mTORC1 in Cancer Progression , 2015, Scientific Reports.

[62]  Graham Thornicroft,et al.  Mental health research priorities for Europe. , 2015, The lancet. Psychiatry.

[63]  Paulo Victor Sgobbi Souza,et al.  Metastatic breast cancer in a man with nonprogressive ataxia and epilepsy , 2015, Neurology.

[64]  U. Hayat,et al.  PTEN inhibition and axon regeneration and neural repair , 2015, Neural regeneration research.

[65]  C. Marmar,et al.  Psychotherapy for Military-Related PTSD: A Review of Randomized Clinical Trials. , 2015, JAMA.

[66]  E. Papakonstanti,et al.  Focus on PTEN Regulation , 2015, Front. Oncol..

[67]  K. Blennow,et al.  Monocyte and microglial activation in patients with mood-stabilized bipolar disorder. , 2015, Journal of psychiatry & neuroscience : JPN.

[68]  Elisabeth B. Binder,et al.  Epigenetics of Stress-Related Psychiatric Disorders and Gene × Environment Interactions , 2015, Neuron.

[69]  K. Ohashi.  Roles of cofilin in development and its mechanisms of regulation , 2015, Development, growth & differentiation.

[70]  C. Eng,et al.  Balancing Proliferation and Connectivity in PTEN-associated Autism Spectrum Disorder , 2015, Neurotherapeutics.

[71]  N. Volkow,et al.  Pathophysiology of Addiction , 2015 .

[72]  E. Choi,et al.  Compromised MAPK signaling in human diseases: an update , 2015, Archives of Toxicology.

[73]  C. Eng,et al.  Neural transcriptome of constitutional Pten dysfunction in mice and its relevance to human idiopathic Autism Spectrum Disorder , 2015, Molecular Psychiatry.

[74]  J. Soares,et al.  Monocyte and Lymphocyte Activation in Bipolar Disorder: A New Piece in the Puzzle of Immune Dysfunction in Mood Disorders , 2014, The international journal of neuropsychopharmacology.

[75]  A. Vercelli,et al.  Neuroprotective and Anti-Inflammatory Roles of the Phosphatase and Tensin Homolog Deleted on Chromosome Ten (PTEN) Inhibition in a Mouse Model of Temporal Lobe Epilepsy , 2014, PloS one.

[76]  Sébastien Mosser,et al.  Inactivation of brain Cofilin-1 by age, Alzheimer's disease and γ-secretase. , 2014, Biochimica et biophysica acta.

[77]  D. Brunner,et al.  Animal models of Huntington's disease for translation to the clinic: Best practices , 2014, Movement disorders : official journal of the Movement Disorder Society.

[78]  C. Eng,et al.  Molecular and Phenotypic Abnormalities in Individuals with Germline Heterozygous PTEN Mutations and Autism , 2014, Molecular Psychiatry.

[79]  Joshua L. Plotkin,et al.  Impaired TrkB Receptor Signaling Underlies Corticostriatal Dysfunction in Huntington’s Disease , 2014, Neuron.

[80]  Seena Fazel,et al.  Risks of all‐cause and suicide mortality in mental disorders: a meta‐review , 2014, World psychiatry : official journal of the World Psychiatric Association.

[81]  Yuxin Yin,et al.  PTENα, a PTEN isoform translated through alternative initiation, regulates mitochondrial function and energy metabolism. , 2014, Cell metabolism.

[82]  G. O’Keeffe,et al.  Expression of endogenous Mkp1 in 6-OHDA rat models of Parkinson’s disease , 2014, SpringerPlus.

[83]  L. Tabernero,et al.  Dual-specificity phosphatases as molecular targets for inhibition in human disease. , 2014, Antioxidants & redox signaling.

[84]  Zhon-Yin Zhang,et al.  Phosphatase of regenerating liver: a novel target for cancer therapy , 2014, Expert opinion on therapeutic targets.

[85]  F. Noble,et al.  Impact of P-glycoprotein at the blood-brain barrier on the uptake of heroin and its main metabolites: behavioral effects and consequences on the transcriptional responses and reinforcing properties , 2014, Psychopharmacology.

[86]  R. Parsons,et al.  PTEN function: the long and the short of it. , 2014, Trends in biochemical sciences.

[87]  I. Lieberam,et al.  Subcellular targeting and dynamic regulation of PTEN: implications for neuronal cells and neurological disorders , 2014, Front. Mol. Neurosci..

[88]  M. Esteller,et al.  Promoter Hypermethylation of the Phosphatase DUSP22 Mediates PKA-Dependent TAU Phosphorylation and CREB Activation in Alzheimer's Disease , 2014, Hippocampus.

[89]  Joshua L. Plotkin,et al.  Impaired striatal function in Huntington's disease is due to aberrant p75NTR signaling , 2014, Rare diseases.

[90]  P. Willner,et al.  The neurobiology of depression and antidepressant action , 2013, Neuroscience & Biobehavioral Reviews.

[91]  B. Liss,et al.  A neuroprotective phase precedes striatal degeneration upon nucleolar stress , 2013, Cell Death and Differentiation.

[92]  M. Rafii.  Update on Alzheimer's disease therapeutics. , 2013, Reviews on recent clinical trials.

[93]  Hongyan Zou,et al.  Differential phosphorylation of Smad1 integrates BMP and neurotrophin pathways through Erk/Dusp in axon development. , 2013, Cell reports.

[94]  G. O’Keeffe,et al.  Mitogen-Activated Protein Kinase Phosphatase (MKP)-1 as a Neuroprotective Agent: Promotion of the Morphological Development of Midbrain Dopaminergic Neurons , 2013, NeuroMolecular Medicine.

[95]  P. Calabresi,et al.  Cerebrospinal fluid biomarkers in Parkinson disease , 2013, Nature Reviews Neurology.

[96]  Xavier Estivill,et al.  A highly expressed miR-101 isomiR is a functional silencing small RNA , 2013, BMC Genomics.

[97]  Darlene R Goldstein,et al.  MAP Kinase Phosphatase 1 (MKP-1/DUSP1) Is Neuroprotective in Huntington's Disease via Additive Effects of JNK and p38 Inhibition , 2013, The Journal of Neuroscience.

[98]  A. Beeser,et al.  Emerging Roles of Atypical Dual Specificity Phosphatases in Cancer , 2013 .

[99]  M. Köhn,et al.  Molecular mechanisms of the PRL phosphatases , 2013, The FEBS journal.

[100]  S. Keyse,et al.  Dual-specificity MAP kinase phosphatases (MKPs) , 2013, The FEBS journal.

[101]  R. Parlato,et al.  Nucleolar activity in neurodegenerative diseases: a missing piece of the puzzle? , 2012, Journal of Molecular Medicine.

[102]  M. Elia,et al.  An atypical patient with Cowden syndrome and PTEN gene mutation presenting with cortical malformation and focal epilepsy , 2012, Brain and Development.

[103]  Zhou Chen,et al.  Effects of PTEN inhibition on regulation of tau phosphorylation in an okadaic acid-induced neurodegeneration model , 2012, International Journal of Developmental Neuroscience.

[104]  Marion Leboyer,et al.  Autism risk factors: genes, environment, and gene-environment interactions , 2012, Dialogues in clinical neuroscience.

[105]  T. Tan,et al.  DUSPs, to MAP kinases and beyond , 2012, Cell & Bioscience.

[106]  B. Ye,et al.  Exression and PI3K/AKT Pathway in Gastric Cancer and its Blockade Suppresses Tumor Growth and Metastasis , 2012, International journal of immunopathology and pharmacology.

[107]  A. Bolino,et al.  Myotubularin phosphoinositide phosphatases: cellular functions and disease pathophysiology. , 2012, Trends in molecular medicine.

[108]  S. Birnbaum,et al.  Pten Deletion in Adult Hippocampal Neural Stem/Progenitor Cells Causes Cellular Abnormalities and Alters Neurogenesis , 2012, The Journal of Neuroscience.

[109]  M. Bates,et al.  The Actin-Severing Protein Cofilin Is Downstream of Neuregulin Signaling and Is Essential For Schwann Cell Myelination , 2012, The Journal of Neuroscience.

[110]  Evan T. Geller,et al.  Patterns and rates of exonic de novo mutations in autism spectrum disorders , 2012, Nature.

[111]  P. Falkai,et al.  Structural synaptic elements are differentially regulated in superior temporal cortex of schizophrenia patients , 2012, European Archives of Psychiatry and Clinical Neuroscience.

[112]  D. Govender,et al.  Gene of the month: PTEN , 2012, Journal of Clinical Pathology.

[113]  D. Mehta,et al.  Gene × environment vulnerability factors for PTSD: The HPA-axis , 2012, Neuropharmacology.

[114]  L. Parker,et al.  Cdc14 Phosphatases Preferentially Dephosphorylate a Subset of Cyclin-dependent kinase (Cdk) Sites Containing Phosphoserine*♦ , 2011, The Journal of Biological Chemistry.

[115]  P. Nicotera,et al.  Neurodegenerative processes in Huntington's disease , 2011, Cell Death and Disease.

[116]  Atsushi Toyoda,et al.  Effects of chronic social defeat stress on MAP kinase cascade , 2011, Neuroscience Letters.

[117]  Y. Ahn,et al.  The genetic association of DUSP6 with bipolar disorder and its effect on ERK activity , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[118]  J. Os,et al.  The size and burden of mental disorders and other disorders of the brain in Europe 2010 , 2011, European Neuropsychopharmacology.

[119]  A. Schober,et al.  Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[120]  S. Roh,et al.  The Interface between Cytoskeletal Aberrations and Mitochondrial Dysfunction in Alzheimer's Disease and Related Disorders , 2011, Experimental neurobiology.

[121]  A. Malafosse,et al.  Alterations in Phosphatidylinositol 3-Kinase Activity and PTEN Phosphatase in the Prefrontal Cortex of Depressed Suicide Victims , 2011, Neuropsychobiology.

[122]  D. Finn,et al.  Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson's disease in the rat , 2011, Neuroscience.

[123]  Qin Liu,et al.  MicroRNA-101 Targets MAPK Phosphatase-1 To Regulate the Activation of MAPKs in Macrophages , 2010, The Journal of Immunology.

[124]  Jim van Os,et al.  The environment and schizophrenia , 2010, Nature.

[125]  H. Schmidt,et al.  A negative regulator of MAP kinase causes depressive behavior. , 2010, Nature medicine.

[126]  Dan Cohen,et al.  Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients. , 2010, The international journal of neuropsychopharmacology.

[127]  S. Akbarian,et al.  Keep the 'phospho' on MAPK, be happy , 2010, Nature Medicine.

[128]  M. Waragai,et al.  α-Synuclein and DJ-1 as Potential Biological Fluid Biomarkers for Parkinson’s Disease , 2010, International journal of molecular sciences.

[129]  A. Renton.  Gene expression and genetic analyses in Parkinson’s diseasewith and without dementia , 2010 .

[130]  J. Ott,et al.  Genome-wide association study identifies genes that may contribute to risk for developing heroin addiction , 2010, Psychiatric genetics.

[131]  E. Schiebel,et al.  Cdc14: a highly conserved family of phosphatases with non-conserved functions? , 2010, Journal of Cell Science.

[132]  G. Pagès,et al.  The dual-specificity MAP kinase phosphatases: critical roles in development and cancer. , 2010, American journal of physiology. Cell physiology.

[133]  H. Manji,et al.  Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia. , 2010, Journal of affective disorders.

[134]  Zhen Yan,et al.  Regulation of AMPA receptor channels and synaptic plasticity by cofilin phosphatase Slingshot in cortical neurons , 2010, The Journal of physiology.

[135]  C. Barbato,et al.  MicroRNA-101 Regulates Amyloid Precursor Protein Expression in Hippocampal Neurons* , 2010, The Journal of Biological Chemistry.

[136]  M. Leśkiewicz,et al.  The decrease in JNK- and p38-MAP kinase activity is accompanied by the enhancement of PP2A phosphate level in the brain of prenatally stressed rats. , 2010, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[137]  H. Akiyama,et al.  Accumulation of tumor-suppressor PTEN in Alzheimer neurofibrillary tangles , 2010, Neuroscience Letters.

[138]  C. Shou,et al.  PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin β1-ERK1/2 and-MMP2 signaling , 2009, Molecular Cancer.

[139]  Kara L. Kuntz-Melcavage,et al.  Gene expression changes following extinction testing in a heroin behavioral incubation model , 2009, BMC Neuroscience.

[140]  A. Chishti,et al.  Dlg1, Sec8, and Mtmr2 Regulate Membrane Homeostasis in Schwann Cell Myelination , 2009, The Journal of Neuroscience.

[141]  Timothy Y. Huang,et al.  Reactive oxygen species regulate a slingshot-cofilin activation pathway. , 2009, Molecular biology of the cell.

[142]  Xing-shu Chen,et al.  Differential Expression of PTEN in Normal Adult Rat Brain and Upregulation of PTEN and p‐Akt in the Ischemic Cerebral Cortex , 2009, Anatomical record.

[143]  K. Patterson,et al.  Dual-specificity phosphatases: critical regulators with diverse cellular targets. , 2009, The Biochemical journal.

[144]  Zhon-Yin Zhang,et al.  PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1/2 pathways. , 2009, Biochemistry.

[145]  Jan Struyf,et al.  Combining gene expression, demographic and clinical data in modeling disease: a case study of bipolar disorder and schizophrenia , 2008, BMC Genomics.

[146]  Pier Paolo Pandolfi,et al.  The PTEN–PI3K pathway: of feedbacks and cross-talks , 2008, Oncogene.

[147]  K. Gould,et al.  The role of Cdc14 phosphatases in the control of cell division. , 2008, Biochemical Society transactions.

[148]  Henrik Kaessmann,et al.  Birth and Rapid Subcellular Adaptation of a Hominoid-Specific CDC14 Protein , 2008, PLoS biology.

[149]  W. Nolen,et al.  A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. , 2008, Archives of general psychiatry.

[150]  C. Pallen,et al.  PRL PTPs: mediators and markers of cancer progression , 2008, Cancer and Metastasis Reviews.

[151]  P. Fitzgerald,et al.  Neuroprotective effects of novel phosphatidylglycerol‐based phospholipids in the 6‐hydroxydopamine model of Parkinson's disease , 2008, The European journal of neuroscience.

[152]  K. Mizuno,et al.  The Slingshot Family of Phosphatases Mediates Rac1 Regulation of Cofilin Phosphorylation, Laminin-332 Organization, and Motility Behavior of Keratinocytes* , 2007, Journal of Biological Chemistry.

[153]  E. Nishida,et al.  Regulation of MAP kinases by MAP kinase phosphatases. , 2007, Biochimica et biophysica acta.

[154]  G. Ming,et al.  BMP gradients steer nerve growth cones by a balancing act of LIM kinase and Slingshot phosphatase on ADF/cofilin , 2007, The Journal of cell biology.

[155]  Suk-Kyeong Jung,et al.  Crystal structure of human slingshot phosphatase 2 , 2007, Proteins.

[156]  Christopher Gillberg,et al.  Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[157]  S. Keyse,et al.  Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases , 2007, Oncogene.

[158]  M. Endo,et al.  LIM Kinase and Slingshot Are Critical for Neurite Extension* , 2007, Journal of Biological Chemistry.

[159]  Eric Butter,et al.  Increasing knowledge of PTEN germline mutations: Two additional patients with autism and macrocephaly , 2007, American journal of medical genetics. Part A.

[160]  S. Lovestone,et al.  Hyperphosphorylation of tau and neurofilaments and activation of CDK5 and ERK1/2 in PTEN-deficient cerebella , 2007, Molecular and Cellular Neuroscience.

[161]  U. Sure,et al.  Implication of PTEN in production of reactive oxygen species and neuronal death in in vitro models of stroke and Parkinson's disease , 2007, Neurochemistry International.

[162]  P. Pandolfi,et al.  Essential Role for Nuclear PTEN in Maintaining Chromosomal Integrity , 2007, Cell.

[163]  D. Craufurd,et al.  Psychiatric disorders in preclinical Huntington’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[164]  G. Sandusky,et al.  Cellular Localization of PRL-1 and PRL-2 Gene Expression in Normal Adult Human Tissues , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[165]  J. Mages,et al.  DUSP Meet Immunology: Dual Specificity MAPK Phosphatases in Control of the Inflammatory Response1 , 2006, The Journal of Immunology.

[166]  C. Elger,et al.  Activation of Akt independent of PTEN and CTMP tumor-suppressor gene mutations in epilepsy-associated Taylor-type focal cortical dysplasias , 2006, Acta Neuropathologica.

[167]  Huaxi Xu,et al.  Tumor suppressor PTEN affects tau phosphorylation, aggregation, and binding to microtubules , 2006 .

[168]  S. Lovestone,et al.  PTEN, a negative regulator of PI3 kinase signalling, alters tau phosphorylation in cells by mechanisms independent of GSK‐3 , 2006, FEBS letters.

[169]  J. Chang,et al.  The association of DUSP6 gene with schizophrenia and bipolar disorder: its possible role in the development of bipolar disorder , 2006, Molecular Psychiatry.

[170]  R. Scott,et al.  Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia , 2006, Schizophrenia Research.

[171]  B. Winblad,et al.  PTEN levels in Alzheimer's disease medial temporal cortex , 2006, Neurochemistry International.

[172]  A. Fournier,et al.  Myelin-Associated Inhibitors Regulate Cofilin Phosphorylation and Neuronal Inhibition through LIM Kinase and Slingshot Phosphatase , 2006, The Journal of Neuroscience.

[173]  J. Dixon,et al.  The structure and regulation of myotubularin phosphatases. , 2005, Current opinion in structural biology.

[174]  H. Wittchen,et al.  Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies , 2005, European Neuropsychopharmacology.

[175]  C Eng,et al.  Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations , 2005, Journal of Medical Genetics.

[176]  F. Shibasaki,et al.  Calcium Signal-induced Cofilin Dephosphorylation Is Mediated by Slingshot via Calcineurin* , 2005, Journal of Biological Chemistry.

[177]  R. Ravid,et al.  Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology , 2005, Journal of neurochemistry.

[178]  J. Bamburg,et al.  Interplay between components of a novel LIM kinase–slingshot phosphatase complex regulates cofilin , 2005, The EMBO journal.

[179]  R. Duman,et al.  Electroconvulsive Seizures Increase the Expression of MAP Kinase Phosphatases in Limbic Regions of Rat Brain , 2005, Neuropsychopharmacology.

[180]  L. Greene,et al.  Analysis of gene expression changes in a cellular model of Parkinson disease , 2005, Neurobiology of Disease.

[181]  Angelika Amon,et al.  Closing mitosis: the functions of the Cdc14 phosphatase and its regulation. , 2004, Annual review of genetics.

[182]  S. McGurk,et al.  Schizophrenia , 2004, The Lancet.

[183]  Xiaoping Yang,et al.  Impairments of ERK signal transduction in the brain in a rat model of depression induced by neonatal exposure of clomipramine , 2003, Brain Research.

[184]  Yasuyuki Shima,et al.  Differential activities, subcellular distribution and tissue expression patterns of three members of Slingshot family phosphatases that dephosphorylate cofilin , 2003, Genes to cells : devoted to molecular & cellular mechanisms.

[185]  Yogesh K. Dwivedi,et al.  Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. , 2003, Archives of general psychiatry.

[186]  D. Barford,et al.  The structure of the cell cycle protein Cdc14 reveals a proline‐directed protein phosphatase , 2003, The EMBO journal.

[187]  A. Monaco,et al.  Myotubularin-related 2 protein phosphatase and neurofilament light chain protein, both mutated in CMT neuropathies, interact in peripheral nerve. , 2003, Human molecular genetics.

[188]  T. Uemura,et al.  Control of Growth Cone Motility and Morphology by LIM Kinase and Slingshot via Phosphorylation and Dephosphorylation of Cofilin , 2003, The Journal of Neuroscience.

[189]  D. McCollum,et al.  Cell Cycle: New Functions for Cdc14 Family Phosphatases , 2002, Current Biology.

[190]  J. Vonesch,et al.  The PtdIns3P phosphatase myotubularin is a cytoplasmic protein that also localizes to Rac1-inducible plasma membrane ruffles. , 2002, Journal of cell science.

[191]  R. Tarter.  Etiology of adolescent substance abuse: a developmental perspective. , 2002, The American journal on addictions.

[192]  H. Ujike,et al.  Gene Expression Related to Synaptogenesis, Neuritogenesis, and MAP Kinase in Behavioral Sensitization to Psychostimulants , 2002, Annals of the New York Academy of Sciences.

[193]  C. Downes,et al.  PTEN: The down side of PI 3-kinase signalling. , 2002, Cellular signalling.

[194]  N. Mailand,et al.  Deregulated human Cdc14A phosphatase disrupts centrosome separation and chromosome segregation , 2002, Nature Cell Biology.

[195]  T. Uemura,et al.  Control of Actin Reorganization by Slingshot, a Family of Phosphatases that Dephosphorylate ADF/Cofilin , 2002, Cell.

[196]  H. Ujike,et al.  Two kinds of mitogen‐activated protein kinase phosphatases, MKP‐1 and MKP‐3, are differentially activated by acute and chronic methamphetamine treatment in the rat brain , 2001, Journal of neurochemistry.

[197]  J. Dixon,et al.  Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling. , 2001, Biochemical and biophysical research communications.

[198]  Yogesh K. Dwivedi,et al.  Reduced activation and expression of ERK1/2 MAP kinase in the post‐mortem brain of depressed suicide subjects , 2001, Journal of neurochemistry.

[199]  J. Bamburg,et al.  Neurodegenerative stimuli induce persistent ADF/cofilin–actin rods that disrupt distal neurite function , 2000, Nature Cell Biology.

[200]  Aldo Quattrone,et al.  Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2 , 2000, Nature Genetics.

[201]  P. Malfertheiner,et al.  Overexpression of transforming growth factor beta-1 (TGF-B1) is associated with reduced pten expression in pancreatic fibrosis and cancer , 2000 .

[202]  Tomohiko Maehama,et al.  Crystal Structure of the PTEN Tumor Suppressor Implications for Its Phosphoinositide Phosphatase Activity and Membrane Association , 1999, Cell.

[203]  M. Lyon,et al.  Mitogen-activated protein kinases in schizophrenia , 1999, Biological Psychiatry.

[204]  S. Hyman,et al.  A Complex Program of Striatal Gene Expression Induced by Dopaminergic Stimulation , 1998, The Journal of Neuroscience.

[205]  Y. Tan,et al.  Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1. , 1998, Biochemical and biophysical research communications.

[206]  H. Schröder,et al.  Transient expression of the mitogen-activated protein kinase phosphatase MKP-1 (3CH134/ERP1) in the rat brain after limbic epilepsy. , 1996, Brain research. Molecular brain research.

[207]  P. Harper.  The epidemiology of Huntington's disease , 1992, Human Genetics.

[208]  G. Cohen.  Alzheimer's disease: clinical update. , 1990, Hospital & community psychiatry.

[209]  N C Andreasen,et al.  Negative v positive schizophrenia. Definition and validation. , 1982, Archives of general psychiatry.

[210]  Yan Wang,et al.  Behavioral defects induced by chronic social defeat stress are protected by Momordica charantia polysaccharides via attenuation of JNK3/PI3K/AKT neuroinflammatory pathway. , 2019, Annals of translational medicine.

[211]  S. Friant,et al.  WANTED - Dead or alive: Myotubularins, a large disease-associated protein family. , 2017, Advances in biological regulation.

[212]  S. Hyman,et al.  Post-traumatic stress disorder , 2015, Nature Reviews Disease Primers.

[213]  Reisa A. Sperling,et al.  Alzheimer's disease , 2015, Nature Reviews Disease Primers.

[214]  E. Downer,et al.  Mitogen-Activated Protein Kinase Phosphatase (MKP)-1 in Nervous System Development and Disease , 2014, Molecular Neurobiology.

[215]  J. Littleton,et al.  The biological function of the Huntingtin protein and its relevance to Huntington's Disease pathology. , 2011, Current trends in neurology.

[216]  S. Tabrizi,et al.  Huntington's disease: clinical presentation and treatment. , 2011, International review of neurobiology.

[217]  A. Reiner,et al.  Genetics and neuropathology of Huntington's disease. , 2011, International review of neurobiology.

[218]  A. Alonso,et al.  Atypical DUSPs: 19 phosphatases in search of a role , 2010 .

[219]  H. Faras,et al.  Autism spectrum disorders , 2010, Annals of Saudi medicine.

[220]  Kenneth Leeds.  Wanted, dead or alive. , 2009, The Hastings Center report.

[221]  C. Pittenger,et al.  Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms , 2008, Neuropsychopharmacology.

[222]  Jeffrey H Kordower,et al.  Animal models of Huntington's disease. , 2007, ILAR journal.

[223]  Yogesh K. Dwivedi,et al.  ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf , 2006, Molecular Psychiatry.

[224]  D. Barford,et al.  The structure and mechanism of protein phosphatases: insights into catalysis and regulation. , 1998, Annual review of biophysics and biomolecular structure.

[225]  J. Bamburg,et al.  Actin depolymerizing factor and cofilin phosphorylation dynamics: response to signals that regulate neurite extension. , 1998, Cell motility and the cytoskeleton.

[226]  N. Moore.  Update on Alzheimer's disease. , 1997, Journal of the Medical Association of Georgia.

[227]  D. Lykken,et al.  Genotype-environment correlations and interactions in the etiology of substance abuse and related behaviors. , 1996, NIDA research monograph.

[228]  T.W.T. Dillon,et al.  What Is a Complex , 1943 .